The National Council of Educational Research and Training (NCERT), under the Ministry of Education, has launched the e-Magic Box app for children aged 3–8. Featuring three AI-powered bots—Katha Sakhi, ...

Druski and Caleb Williams are both immensely popular in their own ways. And that popularity earned them a spot in the NBA Celebrity 3-Point Contest on Friday night in Los Angeles. It generated a lot ...

Trading bots are automated software tools that are used to execute trades depending on predefined strategies or real-time market data on the user’s behalf. These bots can perform tasks like selling, ...

I’m not above doing some gig work to make ends meet. In my life, I’ve worked snack food pop-ups in a grocery store, ran the cash register for random merch booths, and even hawked my own plasma at $35 ...

The ‘Pirates of the Caribbean’ filmmaker is back after nearly a decade, and is ready to skewer how technology has taken over our lives (even more) in that time: “Why is AI helping me write a song or ...

Rotten Tomatoes‘ parent company Versant is denying any tampering is going on with the “Melania” audience scores on the review aggregator website. The Amazon MGM-backed documentary has a 99% audience ...

NBC airs Super Bowl LX; many platforms (Peacock, NFL+, YouTube, etc.) stream it. California bans in-state sports betting; placing/accepting bets is a misdemeanor. Amtrak runs special Capitol Corridor ...

The viral social network for bots reveals more about our own current mania for AI as it does about the future of agents. For a few days this week the hottest new hangout on the internet was a ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

The AI bot takeover of the internet continues apace, and the latest data suggests the surge is being driven less by model-training scrapes and more by the growing use of AI tools as a stand-in for web ...

Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...